Arshad Kashan, Hussain Syed Saddam, Aftab Sommayya
Kashan Arshad Department of Pediatric Endocrinology and Diabetes, University of Child Health Sciences, The Children's Hospital, Lahore, Pakistan.
Syed Saddam Hussain Department of Pediatric Endocrinology and Diabetes, University of Child Health Sciences, The Children's Hospital, Lahore, Pakistan.
Pak J Med Sci. 2025 Aug;41(8):2425-2427. doi: 10.12669/pjms.41.8.11649.
Addison's disease is generally regarded as an autoimmune irreversible, progressive disease leading to the lifelong replacement of glucocorticoids and mineralocorticoids. We are reporting a rare case of a young girl diagnosed with clinically overt Addison's disease whose adrenal function recovered over time. A 10.5 years old girl, known case of celiac disease for five years with good compliance presented at 7.5 years with complaints of dark pigmentation, lethargy, nausea, and vomiting. Physical examination showed hyperpigmentation along with orthostatic hypotension. Biochemical tests confirmed Addison's disease, with normal electrolytes, normal renin and raised ACTH. She was prescribed hydrocortisone tablets and showed significant improvement. She was lost to follow up for three years and presented again with history that she had stopped hydrocortisone 1.5 years back and doing well. She was found clinically stable with no pigmentation, normal growth parameters and normal recent serum electrolytes. Her synacthen testing showed basal ACTH of 282 pg/mL, 30 minutes serum cortisol of 500 nmol/L, and 60 minutes cortisol of 576.63 nmol/L. In her last visit (11 years of age), she was thriving well, with an early morning ACTH of 126 pg/mL and a cortisol level of 510 nmol/L. This is the first case in children with clinical remission of autoimmune Addison's disease. We suggest re-assessing the adrenal axis by synacthen test in children and adolescents with Addison disease, especially those whose hydrocortisone doses are gradually decreasing, to check for remission.
艾迪生病通常被认为是一种自身免疫性的、不可逆的、进行性疾病,会导致糖皮质激素和盐皮质激素终身替代治疗。我们报告了一例罕见的年轻女孩病例,该女孩被诊断为临床显性艾迪生病,但肾上腺功能随时间推移有所恢复。一名10.5岁女孩,患乳糜泻5年且依从性良好,7.5岁时出现皮肤色素沉着、乏力、恶心和呕吐等症状。体格检查显示有色素沉着以及体位性低血压。生化检查确诊为艾迪生病,电解质正常,肾素正常,促肾上腺皮质激素(ACTH)升高。她开始服用氢化可的松片并显示出明显改善。她失访了三年,再次就诊时称1.5年前就停用了氢化可的松,且情况良好。临床检查发现她情况稳定,无色素沉着,生长参数正常,近期血清电解质正常。她的促肾上腺皮质激素释放激素(Synacthen)试验显示基础ACTH为282 pg/mL,30分钟血清皮质醇为500 nmol/L,60分钟皮质醇为576.63 nmol/L。在她最后一次就诊(11岁)时,她发育良好,清晨ACTH为126 pg/mL,皮质醇水平为510 nmol/L。这是儿童自身免疫性艾迪生病临床缓解的首例病例。我们建议对患有艾迪生病的儿童和青少年,尤其是那些氢化可的松剂量逐渐减少的患者,通过促肾上腺皮质激素释放激素试验重新评估肾上腺轴,以检查是否缓解。